Thus, observed potent induction of ferroptosis, GPX4-dependent novel suppression of mTOR pathway and DNA damage repair response in preclinical in vitro model of TC supports GPX4 targeting for therapeutic benefit in advanced therapy-resistant thyroid cancers
Despite the reassuring human data, a cautious approach is mandated
These findings suggest that while FOXO4 is involved in the senescence pathway, it also plays a role in maintaining the viability of senescent Leydig cells by suppressing their apoptotic response, which could contribute to the accumulation of senescent cells [1]
As individuals age, the capacity for glutathione synthesis naturally declines, creating a progressive deficit that may contribute to age-related cellular dysfunction and disease susceptibility
Menezo Y, Elder K, Clement A, Clement P
Therefore, a variety of experimental studies and calculations consistently suggest a short half life in the 23 hour range